Tabla de contenido
Idiomas disponibles
Idiomas disponibles
MED4 ELITE CONTRAINDICATIONS
X = Absolute Contraindication –
Therapy in these situations should not be used in patients who have:
R = Relative Contraindication –
Therapy for these conditions should be used only under the supervision of a
licensed healthcare practitioner in patients who have:
Current clinical signs in the affected region of significant peripheral edema (e.g., deep vein thrombosis, chronic venous insufficiency,
acute compartment syndrome, systemic venous hypertension, congestive heart failure, cirrhosis/liver failure, renal failure).
Significant vascular impairment in the affected region (e.g., from prior frostbite, arteriosclerosis, arterial insufficiency, diabetes,
vascular dysregulation, or other vascular ischemic disease).
Known hematological dyscrasias that predispose to thrombosis (e.g., paroxysmal cold hemoglobinuria, cryoglobulinemia, sickle-cell
disease, serum cold agglutinins).
Tissues inflamed as result of recent injury or exacerbation of chronic inflammatory condition.
Extremities with diffuse or focal impaired sensitivity to pain or temperature that prevent the patient from giving accurate and timely
feedback.
Compromised local circulation or neurologic impairment (including paralysis or localized compromise due to multiple surgical
procedures) in the affected region.
Cognition or communication impairments that prevent them from giving accurate and timely feedback.
An acute, unstable (untreated) fracture in the affected region.
Local malignancy.
Areas of skin breakdown or damage (damaged or at-risk skin) producing uneven heat conduction across the skin (e.g., open wound,
scar tissue, burn or skin graft). Any open wound must be dressed prior to use of the Med4 Elite.
Actively bleeding tissue or hemorrhagic conditions.
Recently radiated tissues or areas affected by heat-sensitive skin diseases (e.g., eczema, psoriasis, vasculitis, dermatitis).
Localized unstable skin condition (e.g., dermatitis, vein ligation, gangrene, or recent skin graft) in the affected region.
Any active local or systemic infection.
Current clinical signs of inflammatory phlebitis, venous ulcers, or cellulitis.
A pregnancy.
Any significant risk factors or current clinical signs of embolism (e.g. pulmonary embolus, pulmonary edema, cerebral infraction, atrial
fibrillation, endocarditis, myocardial infarction, or artheromatous embolic plaque).
A condition in which increased venous or lymphatic return is not desired in the affected extremity (e.g., lymphedema after breast
cancer or other local carcinoma and/or carcinoma metastasis in the affected extremity).
Raynaud's disease or cold hypersensitivity (cold urticaria).
Hypertension, Cardiac failure, extreme low blood pressure, or decompensated cardiac insufficiency.
Children under 18 years old
Had recent toe surgery in the affected region.
Obtunded or with diabetes mellitus, multiple sclerosis, poor circulation, spinal cord injuries, and rheumatoid arthritis.
Decompensated hypertonia in the affected region.
THERAPY MODE
X
X
X
X
X
X
X
X
X
R
X
X
R
X
X
R
X
R
R
R
R
X
R
X
X
R
X
X
R
X
X
R
R
X
X
X
X
X
R
R
R
R
X
X
X
R
X
X
X
X
X
X
X
X
X
X
X
X
X
R
R
X
R
R
R
R
R
R
R
R
R
R
X
R
X
X
Tabla de contenido
